Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy - 14/05/21
, Federico De Grazia a, Marco Vincenzo Lenti b, Roberto Penagini c, d, Roberto Frego e, Sandro Ardizzone f, Edoardo Savarino g, Franco Radaelli h, Matteo Bosani i, Stefania Orlando j, Arnaldo Amato h, Marco Dinelli e, Francesca Ferretti f, Elisabetta Filippi c, d, Maurizio Vecchi c, d, Davide Stradella j, Marco Bardone a, Lodovica Pozzi a, Laura Rovedatti a, Elena Strada a, Antonio Di Sabatino b
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Highlights |
• | UGIB has a prevalence of 0.47% in non-ICU COVID-19 patients and peptic disease is the most common finding. |
• | Half of patients were managed conservatively or with delayed endoscopy. |
• | This is the first report that evaluates incidence of UGIB in COVID-19 patients. |
• | Conservative management and delayed endoscopy could be a successful option in patients with significant respiratory impairment. |
Abstract |
Background |
COVID-19 patients have an increased susceptibility to develop thrombotic complications, thus thromboprophylaxis is warranted which may increase risk of upper gastrointestinal bleeding (UGIB). Our aim was to evaluate incidence of UGIB and use of upper GI endoscopy in COVID-19 inpatients.
Methods |
The medical and endoscopic management of UGIB in non-ICU COVID-19 patients has been retrospectively evaluated. Glasgow Blatchford score was calculated at onset of signs of GI bleeding. Timing between onset of signs of GI bleeding and execution, if performed, of upper GI endoscopy was evaluated. Endoscopic characteristics and outcome of patients were evaluated overall or according to the execution or not of an upper GI endoscopy before and after 24h.
Results |
Out of 4871 COVID-19 positive patients, 23 presented signs of UGIB and were included in the study (incidence 0.47%). The majority (78%) were on anticoagulant therapy or thromboprophylaxis. In 11 patients (48%) upper GI endoscopy was performed within 24h, whereas it was not performed in 5. Peptic ulcer was the most common finding (8/18). Mortality rate was 21.7% for worsening of COVID-19 infection. Mortality and rebleeding were not different between patients having upper GI endoscopy before or after 24h/not performed. Glasgow Blatchford score was similar between the two groups (13;12–16 vs 12;9–15).
Conclusion |
Upper GI bleeding complicated hospital stay in almost 0.5% of COVID-19 patients and peptic ulcer disease is the most common finding. Conservative management could be an option in patients that are at high risk of respiratory complications.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : COVID 19, GBS, ICU, LMWH, UGIB
Keywords : Upper gastrointestinal bleeding, COVID-19, Peptic ulcer
Mappa
Vol 45 - N° 3
Articolo 101521- Maggio 2021 Ritorno al numero
Articolo precedente
- Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma
- Paul McLellan, Julie Henriques, Feryel Ksontini, Solène Doat, Pascal Hammel, Jérome Desrame, Isabelle Trouilloud, Christophe Louvet, Daniel Pietrasz, Dewi Vernerey, Jean-Baptiste Bachet
- Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey
- Debora Basile, Claire Gallois, Fabio Puglisi, Romain Cohen, Diane Goere, Giuseppe Aprile, Come Lepage, Pierre Laurent-Puig, Massimo Di Maio, Thierry Lecomte, Simon Pernot, Aziz Zaanan, Julien Taieb
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.